Human IGFBP-2(Insulin Like Growth Factor Binding Protein 2) CLIA Kit

The Human IGFBP-2 CLIA Kit is a highly sensitive and specific assay designed for the quantitative measurement of Insulin Like Growth Factor Binding Protein 2 (IGFBP-2) in human serum, plasma, and cell culture supernatants. This kit utilizes a chemiluminescent immunoassay (CLIA) technology, which offers superior sensitivity and accuracy compared to traditional ELISA methods.

The assay is based on a sandwich immunoassay principle, where two monoclonal antibodies are used to capture and detect IGFBP-2. The kit includes all necessary reagents and controls for the assay, and the protocol is simple and easy to follow. The assay has a wide dynamic range of 0.156-10 ng/mL, with a lower limit of detection of 0.039 ng/mL. The Human IGFBP-2 CLIA Kit is intended for research use only and is not for diagnostic or therapeutic purposes. This kit is ideal for researchers studying the role of IGFBP-2 in various physiological and pathological conditions, including cancer, diabetes, and growth disorders.